-
Airports in Vietnam apply special process to receive flights from areas affected by COVID-19
prnasia
March 04, 2020
At 3.30pm on March 1, Vietjet flight VJ961 carrying 229 passengers from Incheon (South Korea) touched down at Van Don International Airport in the northeast of Vietnam.
-
Europe on high alert as Coronavirus (Covid-19) spread intensifies
pharmaceutical-technology
March 04, 2020
European countries are on high alert as coronavirus (Covid-19) is spreading rapidly across the region.
-
Applied DNA, Takis Biotech design four Covid-19 vaccine candidates
pharmaceutical-technology
March 04, 2020
Applied DNA Sciences and Takis Biotech have designed four Covid-19 vaccine candidates to help protect against the novel coronavirus.
-
Mateon launches antiviral programme focused on Covid-19
pharmaceutical-technology
March 04, 2020
Mateon Therapeutics has launched an antiviral response programme that will initially focus on Covid-19 disease caused by the novel coronavirus.
-
New findings show SARS drugs can help treat Covid-19
pharmaceutical-technology
March 04, 2020
Researchers in the US have mapped a SARS-CoV-2 protein, which could help use drugs developed to treat SARS coronavirus as effective treatments for the new Covid-19 disease.
-
Novavax starts animal testing of coronavirus vaccine candidates
pharmaceutical-technology
March 03, 2020
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models.
-
Coronavirus deaths cross 3,000; recovery rate in China rises
pharmaceutical-technology
March 03, 2020
The total number of deaths due to coronavirus (Covid-19) has crossed 3,000, as of the end of 1 March. The number of deaths in mainland China stands at 2,912.
-
NIAID Began First Clinical Trial of Remdesivir in the U.S.
Lin Zhang
March 03, 2020
An Investigational New Drug Application (IND) Remdesivir is developed by American drugmaker Gilead Sciences Inc..
-
WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies
contractpharma
March 03, 2020
WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development.
-
Novavax Advances Development of COVID-19 Vaccine
contractpharma
March 03, 2020
Novavax, Inc., a late-stage biotechnology company developing next-gen vaccines for serious infectious diseases, has advanced its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19.